|
Federal Register
Notices
> Notice of Registration - 2009
>
Austin Pharma LLC
FR Doc E9-25882[Federal Register: October 28, 2009 (Volume 74, Number 207)]
[Notices] [Page 55590] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28oc09-118]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 15, 2009, and published in the Federal Register on June
23, 2009, (74 FR 29718), Austin Pharma LLC., 811 Paloma Drive, Suite A, Round
Rock, Texas 78665-2402, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Nabilone (7379)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone Intermediate (9254)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Remifentanil (9739)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Austin Pharma LLC.
to manufacture the listed basic classes of controlled substances is consistent
with the public interest at this time. DEA has investigated Austin Pharma LLC.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state
and local laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above
named company is granted registration as a bulk manufacturer of the basic
classes of controlled substances listed.
Dated: October 21, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E9-25882 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|